Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)

Q: What does CUSIP 15673T100 represent in this 13F holders report?

CUSIP 15673T100 is the security identifier for IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q2 2025?

64 institutional investors reported IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 15673T100

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 22,628,192
Total 13F value: $12,642,486
Share change: -6,936,251
SEC-reported price per share: $0.56
Number of holders: 64
Value change: -$3,582,180
Number of buys: 36
Number of sells: 45
Shares outstanding: 180,747,818

Security key

15673T100

Report period

Q2 2025

Institutions

Top holders

IPSC full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Century Therapeutics, Inc. SEC filings Century Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 15673T100

Newer quarter: Q4 2025

Recent filing periods:

Q3 2026 Q4 2025

Ownership snapshot

Top reported holders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Casdin Capital, LLC

Disclosed value leader

BAYER AKTIENGESELLSCHAFT

Comparable rows

1/15

Latest evidence

31 Mar 2025

13D/G 13F 3/4/5 Lead comparable stake: 3.7% 14 rows are not safely comparable across share classes. 13D/G row: Casdin Capital, LLC Showing 1-6 of 15 holder rows.

Quick read

Casdin Capital, LLC leads the comparable SEC ownership view at 3.7%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Casdin Capital, LLC's linked filing trail.

Comparable ownership Top 1

Casdin Capital, LLC 3.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Casdin Capital, LLC	13D/G 13F Company 13D/G 13F	3.7% Reported 13D/G · 31 Mar 2025	$1,702,527 3,212,316 shares	$0	31 Mar 2025
BAYER AKTIENGESELLSCHAFT	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$18,886,999 12,675,838 shares	—	22 Jun 2021
Versant Venture Capital VI, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$18,127,503 12,166,109 shares	—	09 Aug 2022
FUJIFILM Cellular Dynamics, Inc.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$10,363,258 6,955,207 shares	—	22 Jun 2021
Hyam Levitsky	3/4/5 President of R&D 3/4/5	— mixed-class rows	$2,880,972 706,544 shares mixed-class rows	—	07 Mar 2024
Bain Capital Life Sciences Investors, LLC	13F Company 13F	— denominator unverified	$2,575,332 5,410,361 shares	—	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

22,628,192

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q4 2025 Across Filers

Q4 2025 holders

Q2 2025 holders

Holder diff

Investor	Q4 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q4 2025 value	Q2 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend